Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexsero Booster and Catch-up in Toddlers
NCT00944034Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2009
- Primary completion
- Aug 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 6
01
Overview
A Phase 3 trial of recombinant neisseria meningitidis group B nhba fusion protein in meningococcal disease, meningococcal meningitis, sponsored by Novartis. Started Jul 2009; status: completed.
02
Drugs
recombinant neisseria meningitidis group B nhba fusion protein
03
Conditions
meningococcal diseasemeningococcal meningitis
Beyond the preview
Go deeper on NCT00944034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944034.